Tag: FDAs

FDA’s Høeg plans to scrutinize SSRIs, RSV shots for babies

Tracy Beth Høeg, the newly appointed top drug regulator at the Food and Drug Administration, outlined her priorities

What the FDA’s Moderna rejection means for every vaccine maker

The recent decision by the Food and Drug Administration (FDA) to refuse to review Moderna's flu vaccine has

Changing the FDA’s Vaccine Approval Process Could Threaten COVID, Flu Protection for Children

The U.S. Food and Drug Administration is considering changes to the approval process for vaccines, including COVID vaccines,

Inside the fall of Vinay Prasad, the FDA’s top vaccine official

Vinay Prasad, an official at the Food and Drug Administration, found himself facing a series of challenges. His

Vinay Prasad named FDA’s chief medical and science Officer

Vinay Prasad has been appointed to three key roles at the Food and Drug Administration, solidifying his status

FDA’s Makary evades Covid questions, calls CDC panel a ‘kangaroo court’

In a recent interview on CBS News’ “Face the Nation,” Food and Drug Administration Commissioner Marty Makary addressed

FDA’s Makary pushes back on criticism, explains Covid booster plan

Lawmakers grilled FDA Commissioner Marty Makary on a variety of issues during a Senate budget hearing, including the

D.C. Diagnosis: House bill cuts Medicaid, FDA’s new vaccine policy

Memorial Day is fast approaching, and STAT+ is offering an exclusive deal to celebrate this occasion. You can

FDA’s Conditional Approval Plan Would Unleash Biotech Innovation

The FDA is on the brink of a groundbreaking change that could revolutionize the approval process for rare

FDA’s top medical device safety official fired in Trump-Musk cuts

The Trump administration recently terminated the head of medical device safety at the Food and Drug Administration (FDA),

Updated drug information handout outdoes FDA’s version in clinical trial

A recent clinical trial conducted by researchers at the University of Pittsburgh compared the effectiveness of a one-page

abortion pill, the FDA’s DEI, overdose rates study

This stark disparity highlights the ongoing challenges faced by Black Americans in accessing and receiving adequate care for